Primary Care Insight Report
FP and GP perspectives on a rapidly growing menopause workload, where treatment confidence, digital information, GSM detection, consultation time, and long-term risk assessment are competing inside the same primary care visit.
Audience:
Countries: 6
Survey records:
-Hero findings
– Quick Read — Key Findings
Explore the full report on demand growth, MHT confidence, digital influence, GSM detection, long-term risk, and the emerging shared-care model.
For many family physicians and GPs, menopause care now arrives through several doors at once: vasomotor symptoms, sleep problems, sexual health, genitourinary symptoms, bone health, cardiometabolic risk, and increasingly informed or misinformed requests for hormone and non-hormone treatments. The consultation is no longer only about whether a patient is menopausal. It is about how to fit a multi-system transition into ordinary primary care.
The current NICE menopause guideline, updated in April 2026, emphasizes individualized care, discussion of benefits and risks, symptom-specific management, and specialist input when contraindications or uncertainty make treatment more complex. The same guidance recognizes genitourinary symptoms, HRT choices, and newer non-hormonal options as part of contemporary menopause care.
The survey shows that demand is rising faster than the space available to manage it. Confidence is not absent, but it is graduated. Digital information can improve engagement while also creating expectation and misinformation work. Most importantly, the pattern suggests that the central pressure point is not one drug or one symptom. It is how much clinical reasoning now has to happen inside a standard primary care encounter.
Clinical context: NICE, Menopause: Identification and Management, updated April 2026; NICE, Menopause Recommendations
The survey includes professionals from United States, United Kingdom, Canada, Italy, France, Germany.
MDForLives Research Interpretation
A combined 71.8% report that menopause-related demand has increased, while only 1.1% say it has decreased.
What the pattern suggests: The increase is broad rather than confined to a small subset of practices. Menopause is becoming a more visible and recurring primary care workload.
What may be behind it: Greater public discussion, digital information, evolving treatment conversations, and direct-to-consumer services can all increase awareness and prompt patients to seek care earlier or more actively.
Why it matters: As demand grows, menopause care competes for time with the other chronic and preventive needs already concentrated in primary care.
Social media and health influencers lead at 37.5%, but evolving clinical safety updates are close behind at 31.3%.
What the pattern suggests: Demand growth is being driven by both public culture and medical information. The patient arrives with a narrative that may contain accurate evidence, oversimplified claims, or both.
What may be behind it: Menopause has become a high-visibility health topic across news, social platforms, celebrity advocacy, and digital clinics, increasing the amount of pre-formed opinion entering the consultation.
Why it matters: Primary care now has to interpret the patient’s information environment as part of clinical history-taking, not as a separate communication issue.
Most respondents are at least moderately confident initiating MHT, but only one in five describe complete independence across assessment, initiation, and titration.
What the pattern suggests: The dominant position is capable but conditional. Standard candidates may remain in primary care, while borderline histories and high-risk scenarios preserve a specialist boundary.
What may be behind it: MHT decisions require integration of symptoms, uterine status, thromboembolic risk, breast cancer history, age, time since menopause, patient preference, and route or formulation.
Why it matters: The survey suggests that confidence is not a binary yes-or-no measure. It changes with case complexity, which is why access to specialist input remains important even in a primary-care-led model.
Proactive screening leads at 46.3%, but 40.4% only address localized symptoms when the patient raises them.
What the pattern suggests: The near-even split suggests that GSM visibility depends substantially on whether the clinician opens the conversation first.
What may be behind it: Vaginal dryness, dyspareunia, urinary symptoms, and sexual health concerns may be underreported because they are personal, normalized, or not recognized as part of menopause.
Why it matters: The pattern shows how a condition can remain clinically important yet inconsistently visible when detection depends on self-disclosure during a time-limited visit.
Consultation time leads at 39.7%, ahead of inconsistent guidance, administrative cost pressure, and specialist-network fragmentation.
What the pattern suggests: The main constraint is not lack of patient demand or complete lack of clinical confidence. It is the amount of work that can be completed inside ordinary appointment architecture.
What may be behind it: A single menopause visit can involve symptom assessment, MHT risk discussion, mental health, sexual health, bone health, cardiometabolic risk, medication review, and correction of digital misinformation.
Why it matters: Time pressure can shape which parts of menopause care become visible and which are deferred, even when clinicians recognize their importance.
Shared care between primary care and community gynecology leads at 45.5%, with another 34.9% favoring primary care as the main coordinator.
What the pattern suggests: Respondents are not moving menopause care out of primary care. They are looking for a stronger escalation pathway around it.
What may be behind it: Routine symptom management and preventive care fit naturally in primary care, while contraindications, complex bleeding, refractory symptoms, and high-risk histories can require specialist expertise.
Why it matters: The preferred model appears to be distributed expertise rather than a choice between generalist and specialist ownership.
The rising consultation volume means menopause is becoming a recurring clinical domain for FPs and GPs. The opinions suggest that the pressure comes from frequency and complexity together.
Most respondents can initiate standard MHT, but only a minority describe complete confidence across all scenarios. The hidden reason may be the wide variation in risk profiles and the need for dependable specialist access when uncertainty rises.
Consultation limits are the leading systemic barrier, and the survey also shows long-term cardiovascular, bone, cognitive, metabolic, and sexual-health issues competing for attention. The pattern suggests that omission may reflect appointment architecture rather than lack of awareness.
The survey shows a clear increase in menopause-related demand and a primary care workforce that is engaged rather than disengaged. Most FPs and GPs report at least moderate confidence with MHT, and many already ask proactively about genitourinary symptoms.
The pressure appears when that confidence meets time, digital information, complex risk, and long-term prevention. The preferred future model reflects that tension: primary care remains central, but respondents lean toward shared care rather than isolated ownership. The pattern is less about transferring menopause away from general practice and more about building a care architecture that matches the number of decisions now contained in the menopause visit.
You have read the summary
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
